Sales & Marketing HSA growth and the opportunities emerging for investors and ... Paying attention to the intersection of public policy and business opportunity can be a winning strategy for start-ups and disrupters.
Partner Content Partner Content IATA's CEIV-Pharma Certification or HSA's GDP Certification? 13th Cold Chain Distribution Conference
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.